Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEUPROLIDE Cause Intervertebral disc degeneration? 28 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Intervertebral disc degeneration have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.0% of all adverse event reports for LEUPROLIDE.

28
Reports of Intervertebral disc degeneration with LEUPROLIDE
0.0%
of all LEUPROLIDE reports
7
Deaths
7
Hospitalizations

How Dangerous Is Intervertebral disc degeneration From LEUPROLIDE?

Of the 28 reports, 7 (25.0%) resulted in death, 7 (25.0%) required hospitalization.

Is Intervertebral disc degeneration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does LEUPROLIDE Cause?

Hot flush (9,146) Death (8,772) Intercepted product preparation error (8,621) Syringe issue (7,847) Device leakage (5,861) Wrong technique in product usage process (5,062) Fatigue (4,805) Injection site pain (4,678) Prostatic specific antigen increased (2,432) Asthenia (2,176)

What Other Drugs Cause Intervertebral disc degeneration?

ADALIMUMAB (873) ALENDRONATE (339) ETANERCEPT (311) METHOTREXATE (308) EMTRICITABINE\TENOFOVIR DISOPROXIL (210) PREGABALIN (204) PREDNISONE (202) RITUXIMAB (200) OXYCODONE (184) SODIUM OXYBATE (178)

Which LEUPROLIDE Alternatives Have Lower Intervertebral disc degeneration Risk?

LEUPROLIDE vs LEVALBUTEROL LEUPROLIDE vs LEVAMISOLE LEUPROLIDE vs LEVAQUIN LEUPROLIDE vs LEVEMIR LEUPROLIDE vs LEVETIRACETAM

Related Pages

LEUPROLIDE Full Profile All Intervertebral disc degeneration Reports All Drugs Causing Intervertebral disc degeneration LEUPROLIDE Demographics